Top Page
China Healthwise Holdings
(0348)
China Healthwise Holdings (0348) vs. iShares MSCI Hong Kong ETF (EWH)
China Healthwise Holdings Business Overview & Revenue Model
China Healthwise Holdings Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.70M | 113.58M | 146.32M | 142.06M | 170.08M | 137.85M |
| Gross Profit | 34.99M | 35.00M | 60.29M | 53.27M | 90.99M | 61.06M |
| EBITDA | -9.22M | -20.07M | -117.45M | -45.80M | -89.97M | -45.33M |
| Net Income | -10.20M | -40.28M | -134.56M | -54.27M | -103.05M | -71.45M |
Balance Sheet | ||||||
| Total Assets | 110.90M | 122.05M | 149.67M | 287.66M | 314.10M | 434.28M |
| Cash, Cash Equivalents and Short-Term Investments | 47.17M | 44.72M | 54.28M | 73.02M | 96.91M | 139.92M |
| Total Debt | 107.93M | 103.74M | 108.90M | 109.90M | 90.86M | 113.81M |
| Total Liabilities | 127.86M | 140.43M | 145.27M | 149.01M | 121.03M | 137.99M |
| Stockholders Equity | -16.96M | -18.38M | 4.40M | 138.65M | 193.06M | 296.29M |
Cash Flow | ||||||
| Free Cash Flow | 5.39M | 3.12M | 14.30M | -28.97M | 41.72M | 7.47M |
| Operating Cash Flow | 5.59M | 3.38M | 14.49M | -28.34M | 42.08M | 11.99M |
| Investing Cash Flow | -200.00K | -257.00K | -191.00K | -631.00K | -360.00K | 1.50M |
| Financing Cash Flow | -6.47M | -7.84M | -17.04M | 5.95M | -36.36M | -25.75M |
China Healthwise Holdings Technical Analysis
China Healthwise Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | HK$194.56M | -5.03 | -7.71% | ― | -34.73% | -4642.86% | |
56 Neutral | HK$321.44M | 54.08 | 0.86% | 5.98% | -10.78% | -82.81% | |
52 Neutral | HK$254.79M | -8.88 | -4.89% | 24.56% | -1.68% | -111.10% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | HK$130.98M | ― | ― | ― | -17.97% | 92.26% | |
44 Neutral | HK$482.13M | 35.71 | ― | ― | ― | ― | |
44 Neutral | HK$316.75M | -111.63 | -7.37% | ― | 11.32% | 62.61% |
China Healthwise Holdings Corporate Events
China Healthwise Holdings Limited has announced significant changes in its board composition. Mr. Yang Qiangsheng has resigned as an executive director to focus on personal commitments, while Mr. Fung Wai Ching has been appointed as an independent non-executive director, joining the audit and nomination committees. This appointment ensures the company’s compliance with Hong Kong Stock Exchange listing rules, potentially strengthening its governance and market position.
China Healthwise Holdings Limited has announced the composition of its board of directors and their respective roles within the company. The announcement details the members of the executive and independent non-executive directors, as well as the composition of the Audit, Nomination, and Remuneration Committees. This update is crucial for stakeholders as it outlines the leadership structure and governance of the company, potentially impacting its strategic direction and operational oversight.
China Healthwise Holdings Limited reported its unaudited interim results for the six months ending June 30, 2025, showing a significant turnaround with a profit of HK$1,418,000 compared to a loss of HK$28,663,000 in the same period last year. The improvement was driven by a reduction in general and administrative expenses and a net gain in other income, gains, and losses, despite a decrease in revenue and an increase in finance costs.
China Healthwise Holdings Limited has issued a positive profit alert, indicating a significant financial turnaround for the first half of 2025. The company expects to report a profit of between HK$0.1 million and HK$2 million, compared to a loss of HK$29 million in the same period of 2024. This improvement is attributed to a reversal of impairment losses, effective cost-saving measures, and unrealized fair value gains on financial assets. The announcement highlights the company’s strategic efforts to enhance financial performance, although the results are preliminary and subject to final adjustments.
China Healthwise Holdings Limited has announced that its Board of Directors will convene on August 27, 2025, to approve the unaudited interim results for the first half of the year, consider an interim dividend, and address other business matters. This meeting is significant as it will provide insights into the company’s financial health and operational performance, potentially impacting investor confidence and stakeholder decisions.
China Healthwise Holdings Limited announced the resignation of an independent non-executive director and subsequent changes in the composition of its board committees. This has resulted in non-compliance with certain Hong Kong Stock Exchange listing rules, specifically regarding the required composition of the Nomination Committee, which now lacks a majority of independent non-executive directors.